Immunological Abnormalities in a Group of Patients with Limited Cutaneous Systemic Sclerosis and Prominent Vascular Disease

References

• Harris E N. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324–26
   PubMedGoogle Scholar
• Angles-Cano E, Sultan Y, Clauvel J P. Predisposing factors to thrombosis in systemic lupus erythema-tosus. Possible relation to endothelial cell damage. J Lab Clin Med 1979; 94: 312–22
   PubMed Web of Science ®Google Scholar
• Byron M A, Allington M J, Chapel H M, Mowat A G, Cederholm-Williams S A. Indication of vascular endothelial cell disfunction in systemic lupus erythematosus. Ann Rheum Dis 1987; 46: 741–45
   PubMed Web of Science ®Google Scholar
• Carreras L O, Drefeyn G, Machin S J. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i: 244–46
   Google Scholar
• Harris E N, Asherson R A, Gharavi A E, Morgan S H, Derue G, Hughes G RV. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodies. Br J Haemathol 1985; 59: 227–30
   PubMed Web of Science ®Google Scholar
• Khamashta M A, Harris E N, Gharavi A E, Derue G, Gil A, Vazquez J J, et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849–54
   PubMed Web of Science ®Google Scholar
• Tuma M FF, Missi S M, Oliveira R M, et al. Anticardiolipin antibodies in systemic sclerosis. Clin Exp Rheumatol 1988; 6: 213
   Web of Science ®Google Scholar
• Bamberga P, Asero R, Vismara A, Brucato A, Riboldi P, Meroni P L. Anticardiolipin antibodies in progressive systemic sclerosis (PSS). (Letter). Clin Exp Rheumatol 1987; 5: 387–92
   PubMed Web of Science ®Google Scholar
• Seibold J R, Knight P J, Peter J B. Anticardiolipin antibodies in systemic sclerosis. (Letter). Arthritis Rheum 1986; 29: 1052–53
   PubMedGoogle Scholar
• Seibold J R., Medsger T A, Jr, Winkelstein A, Kelly R H, Rodnan G P. Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1982; 25: 1167–73
   PubMedGoogle Scholar
• Siminovitch K, Klein M, Pruzanski W, et al. Circulating immune complexes in patients with progressive systemic sclerosis. Arthritis Rheum 1982; 25: 1174–79
   PubMedGoogle Scholar
• Tan E M, Rodnan G P, Garcia I, Moroi Y, Fritzler M J, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 1980; 23: 617–25
   PubMed Web of Science ®Google Scholar
• LeRoy E C, Black C, Fleischmayer R, Jablonska S T, Krieg T, Medsger T AJ, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumathol 1988; 15: 202–05
   PubMed Web of Science ®Google Scholar
• Roitt I M, Doniach D. WHO manual of autoimmune serology. WHO, Geneva 1969
   Google Scholar
• Bunn C C, Gharavi A E, Hughes G RV. Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol 1982; 8: 13–17
   PubMedGoogle Scholar
• Akizuki M, Boehm-Truitt M J, Kassan S S, Steinberg A D, Chused T M. Purification of an acidic nuclear protein and demonstration of its antibodies in subsets of patients with sicca syndrome. J Immunol 1977; 119: 932–38
   PubMed Web of Science ®Google Scholar
• Passaleva A, Vannucci F, Bonali A, Iannello G L, Massai G, Ricci M. Autoantibodies to human nuclear antigen(s)-HNA-in connective tissue diseases and other disorders. Clin exp Immunol 1986; 63: 17–25
   PubMed Web of Science ®Google Scholar
• Northway J D, Tan E M. Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin Immunol Immunopathol 1972; 1: 140–54
   Google Scholar
• Zubler R H, Lange G, Lambert P H, Miescher P A. Detection of immune complexes in unheated sera by a modified 125I-Clq binding test. J Immunol 1976; 116: 232–35
   PubMed Web of Science ®Google Scholar
• Passaleva A, Massai G, Morfini M, Longo G, Rossi Ferrini PL, Ricci M. Circulating immune complexes in Haemophilia and von Willebrand's Disease. Scand J Haematol 1983; 31: 466–74
   PubMedGoogle Scholar
• Hay F C, Nineham L J, Roitt I M. Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis. Br Med J 1975; 3: 203–04
   PubMed Web of Science ®Google Scholar
• Elkon K B, Caeiro F, Gharavi A E, Patel B M, Ferjencik P P, Hughes G RV. Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. Clin exp Immunol 1981; 46: 547–56
   PubMed Web of Science ®Google Scholar
• Harris E N, Gharavi A E, Boey M L, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211–14
   Google Scholar
• Harris E N, Gharavi A E, Patel S P, Hughes G RV (1987) Evaluation of the anticardiolipin test: report of an International Workshop held on 4th April 1986. Clin esp Immunol. April, 41986. 68: 215–22
   Google Scholar
• Harris E N, Chan J KH, Asherson R A, Aber V R, Gharavi A E, Hughes G RV. Thrombosis, recurrent fetal loss. and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153–56
   PubMedGoogle Scholar
• Manoussakis M N, Gharavi A E, Drosos A A, Kitridou R C, Moutsopoulos H M. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987; 44: 297–307
   PubMedGoogle Scholar
• Malia R G, Greaves M, Rowlands L M, Lawrence A CK, Hume A, Rowell N R, et al. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin exp Immunol 1988; 73: 456–60
   PubMed Web of Science ®Google Scholar
• Gharavi A E, Harris E N, Asherson R A, Hughes G RV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1–6
   PubMed Web of Science ®Google Scholar
• Horneland M, Rekvig O P, Jorgensen L, Hannestad K. Cultured human endothelial cells display an antigen that is recognized by certain human antichromatin autoantibodies. Clin exp Immunol 1983; 54: 373–77
   PubMed Web of Science ®Google Scholar
• Keane A, Woods R, Dowding V, Roden D, Barry C. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol 1987; 26: 346–50
   PubMedGoogle Scholar
• Pisko E, Gallup K, Turner R, et al. Cardiopulmonary manifestations of progressive systemic sclerosis. Arthritis Rheum 1979; 22: 518–23
   PubMedGoogle Scholar
• French M AH, Harrison G, Penning C A, Cunningham J, Hughes P, Rowell N R. Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies. Ann Rheum Dis 1985; 44: 89–92
   PubMed Web of Science ®Google Scholar
• Fritzler M J, Kinsella T D, Garbutt E. The CREST syndrome: a distinct serological entity with anticentromere antibodies. Am J Med 1980; 69: 520–26
   PubMed Web of Science ®Google Scholar
• Bernstein R M, Stiegerwald J C, Tan E M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin exp Immunol 1982; 48: 43–51
   PubMed Web of Science ®Google Scholar
• Catoggio L J, Bernstein R M, Black C M, Hughes G RV, Maddison P J. Serological markers in progressive systemic sclerosis: clinical correlation. Ann Rhem Dis 1983; 42: 23–27
   PubMed Web of Science ®Google Scholar
• Neri R, Giovannelli L, D'Ascanio A, Tartarelli G, Di Munno O, Bombardieri S. Antinuclear antibodies (ANA) profile in Italian patients with connective tissue diseases (CTD). (Abstract. Clin Exp Rheumatol 1987; 5(S2)22
   Google Scholar
• Steen V D, Ziegler G L, Rodnan G P, Medsger T A, Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984; 27: 125–31
   PubMed Web of Science ®Google Scholar
• Steen V D, Powell D L, Medsger T A, Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31: 196–203
   PubMed Web of Science ®Google Scholar
• Riboldi P, Asero R, Origgi L, Crespi S, Meroni P L, Sguotti C, Sabbadini M G. Antinuclear antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 1985; 3: 205–11
   PubMed Web of Science ®Google Scholar